Osteoarthritis is a leading cause of disability in the United States. This article describes a prioritized research agenda about osteoarthritis management developed for the Patient-Centered Outcomes Research Institute. Evidence gaps were identified by reviewing existing literature and engaging diverse stakeholders to expand and refine gaps. Stakeholders ranked evidence gaps by importance from their perspectives.
Osteoarthritis is a leading cause of disability in the United States. This article describes a prioritized research agenda about osteoarthritis management developed for the Patient-Centered Outcomes Research Institute. Evidence gaps were identified by reviewing existing literature and engaging diverse stakeholders to expand and refine gaps. Stakeholders ranked evidence gaps by importance from their perspectives.
Prioritized evidence gaps included the need to determine or evaluate key patient-centered outcomes; optimal duration, intensity, and frequency of nonsurgical interventions; whether the comparative effectiveness of nonsurgical interventions varies by socioeconomic factors; when and how to transition from nonsurgical to surgical interventions; effective ways to engage patients in selfmanagement and promote long-term behavior change; standardized screening tools that improve early diagnosis; biomechanical strategies that improve symptoms; mechanisms for promoting and delivering coordinated, longitudinal care; and comparative effectiveness of nonsurgical therapies. Searches of PubMed and ClinicalTrials .gov showed many recent and ongoing studies addressing comparative effectiveness of nonsurgical interventions; relatively few of these evaluated treatments across categories (for example, drug therapy vs. weight management) or combined categories of treatment. Few studies addressed other high-priority evidence gaps. O steoarthritis (OA) is a leading form of disability in the United States and can affect weight-bearing and non-weight-bearing joints (1, 2) . It can manifest as a generalized condition affecting multiple joint groups or a localized condition affecting only 1 joint. In OA, structural and then symptomatic failure of 1 or more synovial joints occurs with loss and erosion of articular cartilage, subchondral bone alterations, meniscal degeneration, limited synovial inflammatory response, and bone and cartilage overgrowth (3) .
Physical and psychological factors influence the symptoms of pain and stiffness in the joints affected by OA (4) . Diagnosing OA can be complex, usually requiring a complete clinical history, physical examination, laboratory testing, and radiographic studies to help confirm the suspected diagnosis.
Approximately 27 million adults in the United States are living with OA of 1 or more joints (5) , and this number is projected to increase steadily over the coming decades because of an aging population and an increasing prevalence of obesity (6) . In the Framingham Heart Study cohort, the prevalence of symptomatic knee OA has increased by 4.1% among women and 6.0% among men over 20 years (7) .
Osteoarthritis exacts a tremendous toll on patients and society; it ranks third (behind depression and alcohol misuse) in years lost to disability in the United States (8) .
Health care costs of OA are high-and are increasing. Between 1997 and 2009, the number of hospitalizations with a primary diagnosis of OA more than doubled to an estimated 921 000 (5) . Moreover, the health care costs of inpatient, outpatient, and pharmaceutical treatment have been estimated to be 50% greater than those for persons without the condition (9) .
Nonsurgical management options for OA include analgesics and anti-inflammatory drugs, weight management, exercise, and physical therapy or a combination of these strategies (such as medication plus exercise). When medication and exercise or physical therapy are not enough to decrease pain and improve quality of life, joint surgery is another option. Each management strategy has tradeoffs. For example, persons with OA are twice as likely as those without to develop peptic ulcers (relative risk, 2.49 [95% CI, 1.37 to 4.51]) and renal disease (relative risk, 2.10 [CI, 1.10 to 4.01]), which are probably associated with high use of anti-inflammatory medications (10) . However, evidence is limited on the relative benefits and harms of therapies within each category (medication, physical therapy and exercise, weight loss, or surgery) and there are few direct comparisons of effectiveness, in terms of patient-centered outcomes, among categories or combinations of categories.
Given the high prevalence of OA and the effect on functional status, productivity, and quality of life, optimizing treatments to stabilize symptoms, reduce pain, and maintain functional status should be a high priority. The aim of this project was to develop, in collaboration with diverse stakeholders, a prioritized research agenda about OA management that would reduce uncertainty about nonsurgical management options and optimize patientcentered outcomes.
METHODS
The Appendix Figure (available at www.annals.org) shows our methods, which were previously detailed (11) . We identified and appraised recently published systematic reviews; clinical practice guidelines; and documents on future research needs, including an Agency for Healthcare Research and Quality report identifying future research needs for physical therapy for knee OA (12) . On the basis of recommended areas for future research from these sources, we developed a draft list of 31 possible evidence gaps.
We then engaged a group of 13 stakeholders that included clinical experts and researchers in OA treatment strategies; representatives from federal and nongovernmental funding agencies, relevant professional societies, and related consumer and patient advocacy groups; and health care decision makers and policymakers. The stakeholders provided input on the draft list of evidence gaps. We modified certain gaps and added others on the basis of their feedback and then constructed a relevant analytic framework ( Figure) . Using a forced-ranking prioritization method (13) 
Role of the Funding Source
The Patient-Centered Outcomes Research Institute (PCORI) provided funding for this work. The funding source stipulated the topic for prioritization but did not participate in the literature search, determination of study eligibility criteria, data analysis or interpretation, or preparation or approval of the manuscript for publication. Staff from PCORI did review a draft version of the manuscript and provided suggestions to clarify language describing the process in selecting this topic for prioritization.
RESULTS

Expansion of Evidence Gaps Through Stakeholder Engagement
The stakeholder panel expanded the initial list of 31 evidence gaps to 48. The final list illustrated several common themes: Stakeholders stressed that future research should focus on engaging patients early in the disease process, helping patients navigate treatment options that optimize patient-centered outcomes (for example, negative affect, sleep, pain, and employment), and developing strategies that promote successful long-term engagement in nonsurgical treatment options. New questions suggested by the stakeholders addressed a wide range of evidence gaps related to the unique needs of subpopulations and the comparative effectiveness of diverse interventions.
Stakeholders acknowledged that several patient groups received less attention than others and that it would be important to assess the comparative effectiveness of nonsurgical management strategies by sex, socioeconomic status, and prevalence and severity of comorbid conditions among adults and patients who had previously had surgical treatment of OA. Stakeholders stressed the progressive and chronic nature of OA and the importance of early detection and patient engagement. They also emphasized the importance of setting up patients for success-that is, that treatments should be tailored to patients' abilities, insurance coverage, culture, and preferences.
Stakeholders acknowledged that many current and ongoing studies focus on short-term outcomes and do not necessarily provide the needed information about longterm outcomes reflecting the chronic nature of the disease. They highlighted the importance of shared decisionmaking tools for not only exploring nonsurgical options but also discussing the optimal timing for transition to surgical interventions. They also stressed the incorporation of patient preferences for specific outcomes and their personal characteristics (and the effect of those characteristics on potential efficacy of treatment options) in such shared decision-making tools.
Stakeholder Ranking of Future Research Needs
The Appendix Table (available at www.annals.org) shows the 48 final potential research topics, the number of points each received, and the number of stakeholders who allotted points to each topic. The final ranking divides the possible evidence gaps into a top, middle, and lower tier on the basis of overall score. The top 12 future research needs (Table) prioritized by stakeholders were related to identifying key patient-centered outcomes; determining optimal duration, intensity, and frequency of interventions; examining the effect of socioeconomic differences on management strategies; determining the need for transition from nonsurgical to surgical interventions; promoting long-term behavior change; standardizing screening tools; evaluating biomechanical strategies; developing strategies to help patients engage in key self-management behaviors; promoting coordinated care in today's new health care delivery system; comparing methods for identifying and engaging patients early in the disease process; comparing safety and effectiveness of usual-care nonsurgical therapies; and identifying ways for setting patients up to succeed with nonsurgical management.
Although the stakeholder group expanded the initial list to 48 potential future research needs, 18 of the final questions received no votes (5 questions) or 1 to 2 votes by at most 2 stakeholders (13 questions). Of the 12 questions ranked as highest priority, 2 were new questions that stakeholders suggested (questions focusing on the transition from nonsurgical to surgical interventions and on methods for setting patients up to succeed with nonsurgical management). The other 10 high-priority ranked questions were part of the original list of suggested future research needs. Of the 18 questions ranked low priority, 9 were from our original list and 9 were suggested by stakeholders.
Horizon Scan of Studies Potentially Relevant to Top-Tier Research Questions
The PubMed search identified 4692 articles. Of these, 427 met inclusion criteria, including 92 systematic reviews; 254 randomized, controlled trials; 41 cohort studies; 3 case-control studies; and 37 studies of other design types. Most studies (n ϭ 339) pertained to the comparative effectiveness of available nonsurgical therapies (228 randomized, controlled trials and 79 systematic reviews). Within this set of 339 studies, 119 explored the safety and effectiveness of oral medications (29 systematic reviews; 84 randomized, controlled trials; 3 cohort studies; and 3 other studies). All but 20 of these evaluated oral medications compared with another oral medication or placebo. Relatively few studies evaluated treatments across categories (for example, drug therapy compared with weight management) or combined categories of treatment (for example, drug therapy plus exercise compared with drug therapy only). There were few studies for most of the other high-priority evidence gaps, with only 3 studies targeting ways of determining the need to transition from nonsurgical to surgical interventions and only 7 studies investigating strategies for identifying and engaging patients early in the disease process.
The ClinicalTrials.gov search yielded 153 open, potentially relevant protocols. Of these, 55 were categorized as potentially relevant to the top-tier research questions. Sample sizes of these studies ranged from 8 to 20 000 patients, and estimated completion dates of the studies ranged from currently overdue to June 2017. (Tables 3 to 14 of the Supplement show key characteristics of the recent and ongoing studies relevant to the 12 top-tier future research needs.)
Suggested Research Design Considerations
The Table summarizes the Evidence Synthesis Group's suggestions for appropriate study designs or suggested analyses to address the 12 top-tier research priorities. Proposed designs and analyses to address specific gaps included meta-analysis of individual-patient data, randomized trials, and observational studies requiring collection of new data. Pragmatic clinical trials (14, 15) may be particularly useful for several of these research priorities, as PCORI's recent funding announcement emphasized (16). (Table 15 of the Supplement provides additional details about possible advantages and disadvantages of multiple study designs for each gap.)
DISCUSSION
Osteoarthritis is a common chronic condition that leads to functional limitations, pain, disability, and lost earnings and is associated with high utilization of health care (17, 18) . A key theme that emerged from our research What are the comparative safety and effectiveness of strategies for identifying and engaging patients early in the disease process, particularly fostering healthy behaviors (physical activity and weight management), to prevent progression of and disability from OA?
RCT 11
What are the comparative safety and effectiveness of usual care nonsurgical therapies (pharmacotherapy, injections, physical therapy/exercise, and weight loss) or combinations of usual care nonsurgical therapies to prevent progression of and disability from OA? Are these effects maintained (i.e., long-term outcomes) over time?
RCT and/or meta-analysis of individual-patient data analysis across RCTs 12 How do we best set up patients to succeed with nonsurgical management for OA, incorporating available options and their specific potential barriers for an individual patient?
RCT and/or meta-analysis of individual-patient data analysis across RCTs
ADLs ϭ activities of daily living; OA ϭ osteoarthritis; RCT ϭ randomized, controlled trial; SES ϭ socioeconomic status.
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Research for Osteoarthritis www.annals.orgprioritization process is that future research priorities should focus on attending to patients' needs across the spectrum of the disease, from identification through treatment decisions on the transition from nonsurgical to surgical OA interventions. The most highly ranked research needs focused on identifying the most important patient-centered outcomes and optimizing attributes of nonsurgical intervention (that is, duration, intensity, and frequency) that create sustained changes in patient-centered outcomes. Each nonsurgical treatment method may present tradeoffs between effectiveness in terms of optimizing patient-centered outcomes and other important attributes of treatments (for example, time required for frequent clinician visits and sacrifices involved in dietary modification) that may affect patients' willingness to adopt and maintain treatment options. Thus, direct measurement of patient preferences for different attributes of interventions (including effectiveness and duration, intensity, and frequency) would be highly useful in designing comparative effectiveness studies. The literature search and the review of ongoing research in ClinicalTrials.gov revealed that, although a substantial amount of ongoing research is focused on the comparative safety and effectiveness of usual-care nonsurgical therapies (with most focusing on pharmacotherapies), relatively little work is focused on identifying the most important patient-centered outcomes and how these may map to attributes of nonsurgical treatment strategies.
Many of the other high-priority research needs focused on developing better approaches to help enhance longterm patient engagement in strategies that may prevent the progression of and disability from OA. This factor is reflected in the high ranking of future research needs that focus on promoting long-term behavior change, developing strategies to help patients engage in key selfmanagement behaviors for OA, promoting coordinated OA care in today's new health care delivery system, comparing methods for identifying and engaging patients early in the disease process, and identifying methods for setting patients up to succeed with nonsurgical management.
Osteoarthritis is a chronic illness, so focusing on strategies that promote continuing engagement is a practical approach to optimizing outcomes. Our search of the literature and ongoing studies identified few studies evaluating early engagement of patients, methods for setting patients up for success, and coordinating OA care in today's new health care delivery system. Stakeholders stress that strategies tailored to patients' abilities, insurance, culture, and preferences may enhance the success of OA interventions in the long term.
The list of future research needs that we generated and expanded with stakeholder feedback may not reflect the total range of possible future research. Although we included a diverse group of stakeholders with particular interest in patient-centered research, the panel involved relatively few stakeholders. Another group of stakeholders might add other future research needs or rank the identified future research needs differently. We did not conduct comprehensive systematic reviews pertinent to the identified evidence gaps; therefore, we could not determine with certainty the degree to which prioritized future research needs have already been addressed.
To advance a patient-centered research agenda, future research should focus on addressing patients' needs across the disease spectrum and enhancing long-term engagement in strategies that stabilize the symptoms of OA. A panel of stakeholders representing diverse perspectives identified 12 research areas as the highest priorities for future research of patient-centered management strategies for persons with OA. If studied, these 12 research areas may enhance the patient experience of managing OA symptoms and enable patients to optimize their most valued health outcomes. What are the comparative safety and effectiveness of comprehensive multimodal physical therapy treatments for OA on patient-centered outcomes when compared with exercise alone? Are these effects maintained (i.e., long-term outcomes) over time? 5 4 What are the comparative safety and effectiveness of strategies to increase patient engagement in nonsurgical management strategies to prevent progression of and disability from OA? 5 4 What are valid and reliable instruments used to measure the following patient-centered outcomes for persons with OA: pain/independence in ADLs/instrumental ADLs, patient satisfaction, time to return to work/activities, quality of life, community integration, psychological disability, and self-perceived health? 5 4 What is the minimum clinically important difference for each of these instruments? What cut points should be used to describe clinically meaningful categories in the scale scores created by these instruments? What are effective ways to track and identify OA risk factors and OA progression/outcomes (e.g., electronic health records)? 4 4 What are effective ways for health care professionals to assess OA-specific barriers to physical activity (as a routine component of "vital signs") when screening their adult patients? What are the comparative safety and effectiveness of patient-engagement tools and prompts that promote learning about and management of OA (and pre-OA)?
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2
What is the effect of policy, human resources, and environmental strategies on physical activity behaviors among adults with OA? 4 2 Do the comparative safety and effectiveness of nonsurgical management strategies to prevent progression of and disability from OA differ by comorbid conditions (including obesity)?
3
What are the prevalence and severity of comorbid conditions among adults with OA? 3 3
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